_________
false
כן-פייט ביופרמה בע"מ
2
381
CAN-FITE BIOPHARMA LTD
Corporation no:
512022153
4330
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
17/08/2022
www.isa.gov.il
www.tase.co.il
Reference:
2022-02-104713
Time of broadcast:
14:09
14:09
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Can-Fite: Reports Progress in the Development of Piclidenoson for Osteoarthritis in Pets Through its Partner Vetbiolix
ea164577-6k_canfiteEDGAR2_Bannerless_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
02/08/2022
Address:
Bareket
10
,
Petach-Tikva
47190
,
Tel:
03-9241114
,
03-9213501
Fax:
03-9249378
E-mail address:
motti@canfite.co.il
Company site:
www.canfite.com
Previous names of reporting entity:
Name of the Signatory:
FISHMAN PNINA
Position of Signatory in the reporting corporation:
Director, CFO
Name of Employer Company:
Address:
BAR-ON
2
,
HERZLIA
4658084
Telephone:
03-9241114
Facsimile:
03-9249378
E-mail:
pnina@canfite.co.il
2